Quantitative Structure-Pharmacokinetics Relationships: I. Development of a Whole-Body Physiologically Based Model to Characterize Changes in Pharmacokinetics Across a Homologous Series of Barbiturates in the Rat

[1]  Frederick E. Petry,et al.  Principles and Applications , 1997 .

[2]  Sven Björkman,et al.  Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  Ryosei Kawai,et al.  Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[4]  W. Ebling,et al.  From piecewise to full physiologic pharmacokinetic modeling: Applied to thiopental disposition in the rat , 1994, Journal of Pharmacokinetics and Biopharmaceutics.

[5]  M Rowland,et al.  Relationship between lipophilicity and hepatic dispersion and distribution for a homologous series of barbiturates in the isolated perfused in situ rat liver. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[6]  Tim Morris,et al.  Physiological Parameters in Laboratory Animals and Humans , 1993, Pharmaceutical Research.

[7]  S. Harapat,et al.  Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model , 1993, Journal of Pharmacokinetics and Biopharmaceutics.

[8]  R. Prankerd,et al.  Physico-chemical properties of barbituric acid derivatives. II: Partition coefficients of 5, 5-disubstituted barbituric acids at 25°C , 1992 .

[9]  Malcolm Rowland,et al.  Physiologic modeling of cyclosporin kinetics in rat and man , 1991, Journal of Pharmacokinetics and Biopharmaceutics.

[10]  M. Gumbleton,et al.  Differential Influence of Laboratory Anaesthetic Regimens upon Renal and Hepatosplanchnic Haemodynamics in the Rat , 1990, The Journal of pharmacy and pharmacology.

[11]  F. Åbyholm,et al.  Distribution of cardiac output during pentobarbital versus midazolam/fentanyl/fluanisone anaesthesia in the rat , 1990, Laboratory animals.

[12]  D. Harron.  Clinical pharmacokinetics: Concepts and applications (2nd edn.) , 1989 .

[13]  L. Sheiner,et al.  A semiparametric approach to physiological flow models , 1989, Journal of Pharmacokinetics and Biopharmaceutics.

[14]  Y. Sugiyama,et al.  Prediction of hepatic first-pass metabolism and plasma levels following intravenous and oral administration of barbiturates in the rabbit based on quantitative structure—Pharmacokinetic relationships , 1988, Journal of Pharmacokinetics and Biopharmaceutics.

[15]  M. Rowland,et al.  Relationship between lipophilicity and tubular reabsorption for a series of 5-alkyl-5-ethylbarbituric acids in the isolated perfused rat kidney preparation. , 1988, Journal of pharmaceutical sciences.

[16]  D. Perrier,et al.  Area method for the estimation of partition coefficients for physiological pharmacokinetic models , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[17]  M. Daemen,et al.  The effect of pentobarbitone anaesthesia and hypothermia on the hepatic clearance of indocyanine green and S(−)‐acenocoumarol in the rat , 1986, The Journal of pharmacy and pharmacology.

[18]  B. Gewertz,et al.  Effect of pentobarbital and hemorrhage on renal autoregulation. , 1985, The American journal of physiology.

[19]  D. Longnecker,et al.  Effects of anesthetics on regional hemodynamics in normovolemic and hemorrhaged rats. , 1985, The American journal of physiology.

[20]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[21]  S. Toon,et al.  Structure-pharmacokinetic relationships among the barbiturates in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.

[22]  C. Hull,et al.  Comparative pharmacokinetics of fentanyl and alfentanil. , 1982, British journal of anaesthesia.

[23]  Y. Sugiyama,et al.  Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital, and thiopental in the rat , 1982, Journal of Pharmacokinetics and Biopharmaceutics.

[24]  N. Yata,et al.  Effect of anesthesia on drug disposition in the rat. , 1982, Journal of pharmacobio-dynamics.

[25]  Brian Ford,et al.  Computer-based documentation for the NAG library , 1980, Problems and Methodologies in Mathematical Software Production.

[26]  J. Gross,et al.  Estimation of tissue-to-plasma partition coefficients used in physiological pharmacokinetic models , 1979, Journal of Pharmacokinetics and Biopharmaceutics.

[27]  J. V. van Rossum,et al.  Pharmacokinetics of some homologous series of barbiturates in the intact rat and in the isolated perfused rat liver. , 1977, The Journal of pharmacology and experimental therapeutics.

[28]  R. Lutz,et al.  A preliminary pharmacokinetic model for several chlorinated biphenyls in the rat. , 1977, Drug metabolism and disposition: the biological fate of chemicals.

[29]  H. Remmer.  Induction of drug metabolizing enzyme system in the liver , 1972, European Journal of Clinical Pharmacology.

[30]  T. Arita,et al.  Absorption and excretion of drugs. XXXII. Absorption of barbituric acid derivatives from rat small intestine. , 1967, Chemical & pharmaceutical bulletin.

[31]  B. Brodie,et al.  The role of body fat in limiting the duration of action of thiopental. , 1952, The Journal of pharmacology and experimental therapeutics.

[32]  M. Moor,et al.  Kinetics of distribution and adipose tissue storage as a function of lipophilicity and chemical structure. I. Barbiturates. , 1991, Drug metabolism and disposition: the biological fate of chemicals.

[33]  M. Rowland,et al.  Clinical pharmacokinetics : concepts and applications , 1989 .

[34]  S. Yalkowsky,et al.  Solubility and partitioning. VII: Solubility of barbiturates in water. , 1987, Journal of pharmaceutical sciences.

[35]  P. Flecknell,et al.  Experimental and surgical technique in the rat. , 1980 .

[36]  K. Bischoff,et al.  Thiopental pharmacokinetics. , 1968, Journal of pharmaceutical sciences.